| P2093 | author name string | Tao Wang | |
| | Yi Yang | |
| | Jin Xu | |
| | Zhenlin Zhang | |
| | Meiling Qin | |
| | Puhua Bao | |
| | Wangchao Xu | |
| | Fuxiao Shen | |
| P2860 | cites work | The Parkinson's disease-associated DJ-1 protein is a transcriptional co-activator that protects against neuronal apoptosis | Q24298775 |
| | Imbalances in p97 co-factor interactions in human proteinopathy | Q24307689 |
| | Pathogenic VCP mutations induce mitochondrial uncoupling and reduced ATP levels | Q24336201 |
| | DJ-1 transcriptionally up-regulates the human tyrosine hydroxylase by inhibiting the sumoylation of pyrimidine tract-binding protein-associated splicing factor | Q24338249 |
| | A complex of mammalian ufd1 and npl4 links the AAA-ATPase, p97, to ubiquitin and nuclear transport pathways | Q24594082 |
| | Eukaryotic stress granules are cleared by autophagy and Cdc48/VCP function | Q24629019 |
| | In vivo localization and identification of SUMOylated proteins in the brain of His6-HA-SUMO1 knock-in mice | Q36485205 |
| | SUMO on the road to neurodegeneration | Q36809376 |
| | Valosin-containing protein disease: inclusion body myopathy with Paget's disease of the bone and fronto-temporal dementia | Q37452177 |
| | Oxidative stress-induced assembly of PML nuclear bodies controls sumoylation of partner proteins | Q37721763 |
| | The multiple faces of valosin-containing protein-associated diseases: inclusion body myopathy with Paget's disease of bone, frontotemporal dementia, and amyotrophic lateral sclerosis. | Q37926529 |
| | The Cdc48 machine in endoplasmic reticulum associated protein degradation | Q37938259 |
| | Redox regulation of protein misfolding, mitochondrial dysfunction, synaptic damage, and cell death in neurodegenerative diseases | Q38024581 |
| | PGC1α and mitochondrial metabolism--emerging concepts and relevance in ageing and neurodegenerative disorders | Q38070667 |
| | P97/CDC-48: proteostasis control in tumor cell biology | Q38111095 |
| | Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases | Q38195215 |
| | Ubiquitination in disease pathogenesis and treatment | Q38265657 |
| | Epigenetic mechanisms in neurological and neurodegenerative diseases | Q38379396 |
| | Role of Cdc48/p97 as a SUMO-targeted segregase curbing Rad51-Rad52 interaction | Q39159347 |
| | Proteome-wide identification of SUMO2 modification sites | Q39201092 |
| | Enhanced ATPase activities as a primary defect of mutant valosin-containing proteins that cause inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia | Q39684007 |
| | p97/valosin-containing protein (VCP) is highly modulated by phosphorylation and acetylation | Q39866014 |
| | Ubc9 fusion-directed SUMOylation (UFDS): a method to analyze function of protein SUMOylation | Q40174655 |
| | Inhibition of autophagy, lysosome and VCP function impairs stress granule assembly | Q42030945 |
| | Defining the SUMO-modified proteome by multiple approaches in Saccharomyces cerevisiae | Q42642323 |
| | Postsynaptic spiking homeostatically induces cell-autonomous regulation of inhibitory inputs via retrograde signaling. | Q42788404 |
| | A novel VCP mutation as the cause of atypical IBMPFD in a Chinese family | Q44823590 |
| | Cytosolic degradation of T-cell receptor alpha chains by the proteasome | Q46406320 |
| | Pathological consequences of VCP mutations on human striated muscle | Q48418017 |
| | Involvement of valosin-containing protein (VCP)/p97 in the formation and clearance of abnormal protein aggregates. | Q53545034 |
| | SUMO-1/Ubc9 promotes nuclear accumulation and metabolic stability of tumor suppressor Smad4 | Q73543416 |
| | Exome sequencing reveals VCP mutations as a cause of familial ALS | Q24631513 |
| | Mapping the SUMOylated landscape | Q26799547 |
| | Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis | Q26863439 |
| | State of play in amyotrophic lateral sclerosis genetics | Q26864816 |
| | SUMO1 Affects Synaptic Function, Spine Density and Memory | Q27308933 |
| | The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition | Q27865256 |
| | Detecting endogenous SUMO targets in mammalian cells and tissues | Q27865266 |
| | Quality control of inner nuclear membrane proteins by the Asi complex | Q27932769 |
| | Post-translational modifications regulate class IIa histone deacetylase (HDAC) function in health and disease | Q28088517 |
| | Hexamerization of p97-VCP is promoted by ATP binding to the D1 domain and required for ATPase and biological activities | Q28198216 |
| | ATPase activity of p97-valosin-containing protein (VCP). D2 mediates the major enzyme activity, and D1 contributes to the heat-induced activity | Q28215759 |
| | Hereditary inclusion body myopathy-linked p97/VCP mutations in the NH2 domain and the D1 ring modulate p97/VCP ATPase activity and D2 ring conformation | Q28247784 |
| | Concepts in sumoylation: a decade on | Q28257220 |
| | Emerging functions of the VCP/p97 AAA-ATPase in the ubiquitin system | Q28258706 |
| | Control of p97 function by cofactor binding | Q28266780 |
| | Oxidative stress in neurodegeneration: cause or consequence? | Q28275946 |
| | Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradation | Q28284708 |
| | Ter94 ATPase complex targets k11-linked ubiquitinated ci to proteasomes for partial degradation | Q28292258 |
| | Conformational changes in the AAA ATPase p97-p47 adaptor complex | Q28306308 |
| | Protein modification by SUMO | Q29547919 |
| | VCP is essential for mitochondrial quality control by PINK1/Parkin and this function is impaired by VCP mutations | Q30540665 |
| | Pathogenic VCP/TER94 alleles are dominant actives and contribute to neurodegeneration by altering cellular ATP level in a Drosophila IBMPFD model | Q33815368 |
| | Uncovering global SUMOylation signaling networks in a site-specific manner | Q34041994 |
| | Critical role of VCP/p97 in the pathogenesis and progression of non-small cell lung carcinoma | Q34117172 |
| | The VCP/p97 system at a glance: connecting cellular function to disease pathogenesis. | Q34178673 |
| | Generation of human induced pluripotent stem cells from urine samples. | Q34310664 |
| | The biology of proteostasis in aging and disease | Q34467650 |
| | Nucleocytoplasmic shuttling of valosin-containing protein (VCP/p97) regulated by its N domain and C-terminal region | Q34625857 |
| | The complexities of p97 function in health and disease | Q34632255 |
| | Cellular functions of Ufd2 and Ufd3 in proteasomal protein degradation depend on Cdc48 binding. | Q35102083 |
| | Structural insights into the p97-Ufd1-Npl4 complex. | Q35568482 |
| | The Role of SUMO-Conjugating Enzyme Ubc9 in the Neuroprotection of Isoflurane Preconditioning Against Ischemic Neuronal Injury | Q35619730 |
| | A functional deficiency of TERA/VCP/p97 contributes to impaired DNA repair in multiple polyglutamine diseases | Q35976721 |
| | Dual recruitment of Cdc48 (p97)-Ufd1-Npl4 ubiquitin-selective segregase by small ubiquitin-like modifier protein (SUMO) and ubiquitin in SUMO-targeted ubiquitin ligase-mediated genome stability functions | Q36215827 |
| P433 | issue | 27 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | protein sumoylation | Q3503705 |
| P304 | page(s) | 14373-14384 | |
| P577 | publication date | 2016-05-13 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Pathogenic Mutations in the Valosin-containing Protein/p97(VCP) N-domain Inhibit the SUMOylation of VCP and Lead to Impaired Stress Response | |
| P478 | volume | 291 | |